Your browser doesn't support javascript.
loading
Synthesis and Characterization of Melatonin-Loaded Chitosan Microparticles Promote Differentiation and Mineralization in Preosteoblastic Cells.
Huang, Ren-Yeong; Hsiao, Po-Yan; Mau, Lian-Ping; Tsai, Yi-Wen Cathy; Cochran, David L; Weng, Pei-Wei; Cheng, Wan-Chien; Chung, Chi-Hsiang; Huang, Yi-Cheng.
Afiliación
  • Huang RY; School of Dentistry, Tri-Service General Hospital and National Defense Medical Center, Taipei, Taiwan.
  • Hsiao PY; Graduate of Life Sciences, National Defense Medical Center, Taipei, Taiwan.
  • Mau LP; Department of Periodontics, Chi Mei Medical Center, Tainan, Taiwan.
  • Tsai YC; Department of Health and Nutrition, Chia Nan University of Pharmacy & Science, Tainan, Taiwan.
  • Cochran DL; Department of Senior Services, Southern Taiwan University of Science and Technology, Tainan, Taiwan.
  • Weng PW; School of Dentistry, Tri-Service General Hospital and National Defense Medical Center, Taipei, Taiwan.
  • Cheng WC; Department of Periodontics, The University of Texas Health Science Center at San Antonio, San Antonio, Tex.
  • Chung CH; Department of Orthopaedics, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Huang YC; Department of Orthopaedics, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
J Oral Implantol ; 46(6): 562-570, 2020 Dec 01.
Article en En | MEDLINE | ID: mdl-32838427
ABSTRACT
In terms of a novel scaffold with well good osteoinductive and osteoconductive capacity, melatonin (Mel) possesses positive effects on chemical linkage in scaffold structures, which may allow osteogenic differentiation. The aim of this study is to fabricate Mel-loaded chitosan (CS) microparticles (MPs) as a novel bone substitute through generating a Mel sustained release system from Mel-loaded CS MPs and evaluating its effect on the osteogenic capacity of MC3T3-E1 in vitro. The physical-chemical characteristics of the prepared CS MPs were examined by both Fourier transform infrared spectroscopy and scanning electron microscopy. The released profile and kinetics of Mel from MPs were quantified, and the bioactivity of the released Mel on preosteoblastic MC3T3-E1 cells was characterized in vitro. An in vitro drug release assay has shown high encapsulation efficiency and sustained release of Mel over the investigation period. In an osteogenesis assay, Mel-loaded CS MPs have significantly enhanced alkaline phosphatase (ALP) mRNA expression and ALP activity compared with the control group. Meanwhile, the osteoblast-specific differentiation genes, including runt related transcription factor 2 (Runx2), bone morphogentic protein-2 (Bmp2), collagen I (Col I), and osteocalcin (Ocn), were also significantly upregulated. Furthermore, quantificational alizarin red-based assay demonstrated that Mel-loaded CS MPs notably enhanced the calcium deposit of MC3T3-E1 compared with controls. In essence, Mel-loaded CS MPs can control the release of Mel for a period of time to accelerate osteogenic differentiation of preosteoblast cells in vitro.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quitosano / Melatonina Idioma: En Revista: J Oral Implantol Año: 2020 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quitosano / Melatonina Idioma: En Revista: J Oral Implantol Año: 2020 Tipo del documento: Article País de afiliación: Taiwán